TY - JOUR
T1 - Coronavirus disease 2019 in Latin American patients with multiple sclerosis
AU - Fragoso, Yara D.
AU - Schiavetti, Irene
AU - Carmisciano, Luca
AU - Ponzano, Marta
AU - Steinberg, Judith
AU - Treviño-Frenk, Irene
AU - Ciampi, Ethel
AU - Vecino, Maria Cecilia A.
AU - Correa, Edgar P.
AU - Carcamo, Claudia
AU - Gomes, Sidney
AU - Pimentel, Maria Lucia V.
AU - Santos, Gutemberg A.C.
AU - Vrech, Carlos
AU - Winckler, Thereza C.A.
AU - Sormani, Maria Pia
N1 - Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2021/10
Y1 - 2021/10
N2 - Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and a confirmed diagnosis of COVID-19 from five Latin American countries. Fifteen patients (20.5%) were hospitalized and two patients died. The use of anti-CD20 therapies was the only risk factor associated to hospitalization and death. Despite the small sample size, this study highlights the awareness regarding therapeutic options for MS during the pandemic.
AB - Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and a confirmed diagnosis of COVID-19 from five Latin American countries. Fifteen patients (20.5%) were hospitalized and two patients died. The use of anti-CD20 therapies was the only risk factor associated to hospitalization and death. Despite the small sample size, this study highlights the awareness regarding therapeutic options for MS during the pandemic.
KW - COVID-19
KW - Multiple sclerosis
KW - ocrelizumab
KW - Pandemic
KW - rituximab
UR - http://www.scopus.com/inward/record.url?scp=85111283054&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111283054&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2021.103173
DO - 10.1016/j.msard.2021.103173
M3 - Letter
AN - SCOPUS:85111283054
VL - 55
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
SN - 2211-0348
M1 - 103173
ER -